New research finds that CAR T-cell therapy, developed for blood cancers, dramatically reduced disease activity in every rheumatoid arthritis patient treated. Three achieved medication-free remission after a single infusion.
CAR T-cell therapy emerged from cancer research as one of the most targeted biological interventions ever developed. The approach engineers a patient’s…